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Abstract
Aspergillus fumigatus causes invasive pulmonary disease in immunocompromised hosts
and allergic asthma in atopic individuals. We studied the contribution of lung eosinophils to
these fungal diseases. By in vivo intracellular cytokine staining and confocal microscopy,
we observed that eosinophils act as local sources of IL-23 and IL-17. Remarkably, mice
lacking eosinophils had a >95% reduction in the percentage of lung IL-23p19+ cells as
well as markedly reduced IL-23 heterodimer in lung lavage fluid. Eosinophils killed A.
fumigatus conidia in vivo. Eosinopenic mice had higher mortality rates, decreased recruit-
ment of inflammatory monocytes, and decreased expansion of lung macrophages after
challenge with conidia. All of these functions underscore a potential protective role for
eosinophils in acute aspergillosis. Given the postulated role for IL-17 in asthma pathogen-
esis, we assessed whether eosinophils could act as sources of IL-23 and IL-17 in models
where mice were sensitized to either A. fumigatus antigens or ovalbumin (OVA). We
found IL-23p19+ IL-17AF+ eosinophils in both allergic models. Moreover, close to 95% of
IL-23p19+ cells and >90% of IL-17AF+ cells were identified as eosinophils. These data
establish a new paradigm in acute and allergic aspergillosis whereby eosinophils act not
only as effector cells but also as immunomodulatory cells driving the IL-23/IL-17 axis and
contributing to inflammatory cell recruitment.
Author Summary
The opportunistic fungus, Aspergillus fumigatus, causes a spectrum of diseases ranging
from invasive aspergillosis in the severely immunosuppressed to allergic asthma in atopic
individuals. Here we explored the contribution of eosinophils, a type of white blood cell,
to host defenses and pathogenesis in murine models of invasive pulmonary aspergillosis
and asthma. We found eosinophils co-produce the cytokines IL-23 and IL-17 in both
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aspergillosis models as well as a model of OVA-induced asthma. Eosinophils killed the
conidia (spores) of A. fumigatus in vivo and mice that lacked eosinophils were more sus-
ceptible to invasive aspergillosis. These observations suggest eosinophils play a more
prominent role in defenses against invasive pulmonary aspergillosis than heretofore
appreciated and identify eosinophil-derived IL-23 and IL-17 as potential therapeutic tar-
gets in allergic asthma.
Introduction
Aspergillus fumigatus is an opportunistic mold that produces conidia that are both small (2.5–
3 μm in diameter) and readily airborne [1]. These characteristics make A. fumigatus conidia
easily dispersible, while also promoting access to the alveolar spaces in the human airway [2].
It is estimated that on average, individuals inhale hundreds of conidia a day [3]. Despite such
frequent exposure, in immunocompetent hosts A. fumigatus is rarely pathogenic. Its ability to
cause disease is dependent on the immunological status of the host. Thus, in immunocompro-
mised individuals, particularly those with quantitative or qualitative phagocyte defects; conidia
can germinate and invade lung parenchyma resulting in a highly lethal infection known as
invasive aspergillosis (IA). It is estimated that >200,000 people develop life-threatening IA
annually [4]. In atopic patients and about 2–15% of patients with cystic fibrosis, sensitization
to A. fumigatus can lead to allergic reactions that can drive asthma pathogenesis and lead to
allergic bronchopulmonary aspergillosis (ABPA) [2,5]. Globally, approximately 5 million peo-
ple suffer from ABPA [6].
Although eosinophilia is a hallmark of several allergic diseases including ABPA and severe
asthma with fungal sensitization (SAFS) [7,8], comparatively less is known about the involve-
ment of eosinophils in acute aspergillosis. O’Dea et al. correlated levels of fungal cell wall chitin
with eosinophil recruitment to the lungs in response to repeated aspiration of A. fumigatus
conidia [9]. Lilly et al. [10] have shown that ΔdblGATA-1 mice (which lack eosinophils) infected
with the ATCC 13073 strain of A. fumigatus conidia suffer from higher fungal burdens than WT
mice. These studies also linked eosinopenia to lower levels of IL-17A two days post-infection
[10]. IL-17A exists as a disulfide-linked homodimer and binds with high affinity to the IL-17RA/
RC complex. IL-17A also forms a disulfide-linked heterodimer with IL-17F [11,12]. IL-17F can
exist as a homodimer as well, binding the same IL-17R complex. For clarity, the IL-17RA/RC
ligands will be referred heretofore as IL-17, unless otherwise specified.
IL-17 production is either induced or augmented by IL-23, which is a heterodimeric cyto-
kine composed of IL-23p19 and IL-12p40 subunits. The relationship between IL-23 and IL-17
is known as the IL-23/IL-17 axis [11]. IL-23 is among a group of cytokines that activate signal
transducer and activator of transcription (STAT)-3 [13].
A. fumigatus readily elicits IL-23 and IL-17 production from the lungs after exposure [14].
Although recognized primarily for the induction of neutrophilia, pro-inflammatory cytokines
such as IL-6 and IL-1β, and the up-regulation of antimicrobial peptides [15], IL-17 has been
reported to induce the recruitment of eosinophils in a model of chronic aspergillosis [16].
High levels of IL-17 have also been correlated with symptom severity in allergic asthma [17]. A
remarkably large number of innate and adaptive immune cell types has been reported to be
capable of producing IL-17, including γδ T cells, invariant natural killer T cells, type 3 innate
lymphoid cells (ILC3s), neutrophils, macrophages, CD8+ T cells (Tc17) and CD4
+ T cells
(TH17) [12,15,18,19,20].
IL-23/IL-17-Producing Eosinophils in Aspergillosis
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The cellular source of IL-23 has primarily been studied in connection to TH17 development.
In the context of this paradigm, antigen presenting cells such as dendritic cells and macro-
phages have been identified as its main sources [11]. Here, we show that eosinophils are a local
source of IL-23 and IL-17 in response to both acute A. fumigatus infection and in two different
asthma models. In addition, we show that eosinophils are able to associate with and kill A.
fumigatus conidia. We also investigate their function as immunomodulators in acute aspergil-
losis by regulating the recruitment of inflammatory monocytes and the expansion of macro-
phages in the lungs. Finally, we describe their ability to confer protection against mortality in
acute aspergillosis. Taken together, our findings support a paradigm whereby eosinophils and
eosinophilic production of IL-23 and IL-17 are beneficial to defenses against invasive aspergil-
losis but deleterious to the host in allergic disease.
Results
Eosinophils as sources of innate IL-23p19 and IL-17A in acute
pulmonary aspergillosis
A. fumigatus has been shown to stimulate the IL-23/IL-17 axis before adaptive responses are
mounted [14]. Therefore, we sought to identify innate sources of the components of the IL-23/
IL-17 axis in the lungs after challenge with A. fumigatus conidia. By in vivo intracellular cyto-
kine staining (ICS) we uncovered a cell population co-producing IL-23p19 and IL-17A in the
lungs of C57Bl/6 mice within the first eight hours of infection with 5x107 A. fumigatus conidia
(Fig 1A). To identify the cell type(s) responsible for their production, the IL-23p19+ IL-17A+
population was sorted 8 h post-infection (Fig 1A). In accordance with eosinophil morphology,
95% of the sorted cells stained strongly with eosin in their cytoplasm, and their nuclei were
characteristically polymorphous [21]. We also assessed the IL-23p19+ IL-17A+ population in
BALB/c mice acutely infected with A. fumigatus and found the cells were Siglec-F+ CD11b+
and CD11c- (Fig 1B). This pattern of surface marker expression has been shown to accurately
define eosinophils in the murine lungs [22]. However, in mice where eosinophilopoiesis is dis-
rupted (ΔdblGATA-1; BALB/c background), IL-23p19+ IL-17A+ cells were largely absent (Fig
1B).
To further confirm eosinophils express IL-17A, we infected IL-17AGFP/GFP mice in the
C57Bl/6 background. Due to the autofluorescence exhibited by eosinophils and alveolar mac-
rophages in the channel used to detect GFP signal [23,24], we stained cells with a monoclonal
antibody against GFP conjugated to Alexa Fluor 647. We found that eosinophils (Siglec-F+
CD11c-) indeed expressed GFP in the IL-17A reporter mouse line (Fig 1C). IL-23 and IL-17
production is not a universal feature of all fungal stimulated eosinophil populations as co-incu-
bation of bone marrow-derived eosinophils (BM-eos) with A. fumigatus conidia, zymosan or
LPS elicited levels of these cytokines that were below the lower limits of detection as measured
by an ELISA that was sensitive to 4 pg/ml. In addition, there was no signal over baseline when
the stimulated BM-eos were examined by ICS. Levels of IL-23 and IL-17 remained undetect-
able even following stimulation of the bone marrow-derived eosinophils with IL-5, IL-1β,
GM-CSF, IL-17E, PGE2, transforming growth factor-β and IL-6 over the time and concentra-
tion ranges stated in Materials and Methods. Moreover, stimulation with IL-23 failed to elicit
detectable IL-17 (<4 pg/ml) and stimulation with IL-17AA did not result in detectable IL-23
(<4 pg/ml).
To our knowledge, this is the first report showing that eosinophils express IL-23p19. To fur-
ther explore this finding, we looked for pulmonary IL-23 sources by comparing eosinophil-
deficient ΔdblGATA-1 and wild-type BALB/c mice challenged with A. fumigatus conidia (Fig
2A). In comparison to BALB/c mice, ΔdblGATA-1 mice exhibited a>95% reduction in the
IL-23/IL-17-Producing Eosinophils in Aspergillosis
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percentage of IL-23p19+ cells detected in the lungs (Fig 2B). Nearly all (96.9%) IL-23p19+ cells
in WT mice were found to be in the eosinophil (Siglec-F+ CD11c-) gate (Fig 2C). Moreover,
the majority (87.1%) of eosinophils recruited to the lungs were IL-23p19+ (Fig 2C). As func-
tional IL-23 is comprised of IL-23p19 and IL-12p40 subunits, we confirmed that IL-23 hetero-
dimer was indeed produced in acutely infected lungs, and that their levels as measured by
ELISA were significantly diminished in the absence of eosinophils (Fig 2D). In conclusion,
eosinophils are the predominant local source of IL-23 in this acute aspergillosis model.
Fig 1. Eosinophils as sources of IL-23p19 and IL-17. (A) C57Bl/6 mice were infected with 5x107 AF293 conidia and then treated 2 hours later with
500 μg intraperitoneal (IP) monensin. Mice were euthanized 8 hours post-infection, lung single-cell suspensions were made and ICS performed on fixed
and permeabilized cells with anti-IL-23p19-eFluor 660 and anti-IL-17A-PECy7. FACS analysis uncovered a population producing both cytokines. That
population was sorted and stained with H&E, revealing cells consistent with eosinophil morphology (i.e. polymorphous nucleus and pink cytoplasm). Scale
bar corresponds to 20μm (and 3μm in figure inset). FACS plot representative of 3 experiments, each of which had 2 mice. (B) An IL-23p19+ IL-17A+
population was also detected in BALB/c mice infected with 5x107 AF293 conidia, which was almost completely absent in ΔdblGATA-1 mice. Further
characterization of the IL-23p19+ IL-17A+ population by surface markers confirmed they were eosinophils (Siglec-F+ CD11b+ CD11c-). FACS plots
representative of 3 experiments with 3 mice per group. (C) IL-17A-GFP reporter mice were infected with 5x107 AF293 conidia. Two days post infection,
eosinophils (Siglec-F+ CD11c-) were assessed for the expression of GFP. FACS plot is representative of 3 separate experiments.
doi:10.1371/journal.ppat.1006175.g001
IL-23/IL-17-Producing Eosinophils in Aspergillosis
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Given that IL-23 can induce and augment IL-17 production, we next looked at whether the
low IL-23 levels found in eosinophil-deficient ΔdblGATA-1 resulted in reduced IL-17 produc-
tion by inflammatory cells recruited to the lungs following A. fumigatus challenge. However,
Fig 2. Eosinophils are a significant source of IL-23p19 in acute aspergillosis. (A)ΔdblGATA-1 mice lack eosinophils
(Siglec-F+ CD11c-) after infection with 5x107 AF293 conidia when compared to BALB/c mice. Left panel shows representative
FACS plots whereas right panel shows mean ±SEM (n = 5–6 mice/group) percentage of Siglec-F+ CD11c- cells. P < 0.0001
comparing groups. (B) Intracellular IL-23p19 staining of lung cells of AF293-infected BALB/c andΔdblGATA-1 mice after
treatment with monensin shows fewer IL-23p19+ cells in the absence of eosinophils 8h post infection. Left panel shows
representative FACS plots whereas right panel shows mean ±SEM (n = 5–6 mice/group) percentage of IL-23p19+ cells
P < 0.0001 comparing groups. (C) ICS was performed on BALB/c mice infected with AF293 as in B. Left panel shows IL-
23p19+ gate (maroon) overlaid onto all live cells (gray) in the Siglec-F vs. CD11c window. The plot shows the mean ± standard
deviation (SD) of IL-23p19+ events found within the eosinophil gate (Siglec-F+ CD11c-). Right panel shows the shift in the IL-
23p19 channel of the eosinophil population compared to FMO/isotype control in a representative histogram. The mean ±SD of
Siglec-F+ CD11c- cells which were also IL-23p19+ is shown in the plot. Each plot is representative of 2 separate experiments
with a total n = 5 mice. (D) BALF from BALB/c andΔdblGATA-1 mice were collected 60 h after challenge. IL-23 levels, as
measured by an ELISA specific for the IL-23p19/IL-12p40 heterodimer, were significantly reduced (p < 0.05, n = 6/group) in
eosinopenic mice.
doi:10.1371/journal.ppat.1006175.g002
IL-23/IL-17-Producing Eosinophils in Aspergillosis
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expression of IL-17AF by macrophages, inflammatory monocytes, neutrophils and non-mye-
loid (CD11b-, CD11c-, Ly6G-) cells was not significantly different comparing lung cells from
wild-type and ΔdblGATA-1 mice (S1 Fig).
Localization of IL-23p19 and IL-17A in pulmonary eosinophils by
confocal microscopy
To confirm that eosinophils make IL-23p19 and IL-17A and to assess the intracellular location
of these cytokines, we performed confocal microscopy on cells obtained by bronchoalveolar
lavage 8 and 54 hours post-infection with A. fumigatus (Fig 3). Cells were identified as eosino-
phils if they had granules that stained positive for eosinophil peroxidase (EPX, Fig 3A and 3B)
or major basic protein (MBP, Fig 3C and 3D). Staining for IL-23p19 and IL-17A was observed
in 97.7 ± 1.2% (n = 130 eosinophils counted on 7 cytospin slides) and 90.9 ± 2.6% (n = 66
eosinophils counted on 5 cytospin slides), respectively, of the eosinophils examined. Moreover,
IL-23p19 staining was observed exclusively in eosinophils (Fig 3A). Zero out of 711 cells that
did not stain for EPX or MBP examined by confocal microscopy exhibited positive staining for
IL-23p19. In contrast, IL-17A staining was more promiscuous (Fig 3B). Neither cytokine co-
localized on a consistent basis with MBP- or EPX-positive granules.
Eosinophils associate with and kill A. fumigatus
To further characterize the innate eosinophil response to acute pulmonary aspergillosis, we
assessed their recruitment over the first three days of infection. From day 1 to day 3 post-infec-
tion, the percentage of total leukocytes in the lungs that were eosinophils (Siglec-F+ CD11c-)
did not significantly change (Fig 4A). However, an increase in the number of eosinophils was
observed (Fig 4B). Consistent with data from Mesnil et al. [25], uninfected BALB/c mice had
detectable but relatively low numbers of resident eosinophils (Fig 4B).
To quantitatively assess the ability of eosinophils to associate with and kill A. fumigatus
conidia in vivo, we used the Fluorescent Aspergillus Reporter (FLARE) assay developed by
Jhingran et al. [26]. As this assay does not distinguish between conidia that are internalized
from those that are surface-bound, the term “association” is used here to describe binding with
or without phagocytosis. The FLARE assay exploits the instability of fluorescent proteins (i.e.,
dsRed) in denaturing environments such as phagolysosomes to assess the fate (i.e., viability) of
conidia associated with a leukocyte of interest. Labeling dsRed-expressing conidia with a trace
fluorophore, here we used Alexa Fluor 633, allows for the detection of live conidia (dsRed+ AF
633+) and dead conidia (dsRed- AF633+).
Using the FLARE assay, the capacity of eosinophils to associate with and kill conidia in the
lungs of infected BALB/c mice was assessed on days one and three post-infection. Association
was calculated by adding the proportion of cells associated with live conidia (Gate R1) to the
proportion of cells associated with dead conidia (Gate R2). The number of eosinophils found
to be associated with conidia remained constant from day one to day three post-infection (Fig
4C and 4D). However, a significant increase in conidial killing was observed from day one
(36.9%) to day three (68.6%) post-infection (Fig 4C and 4D).
Eosinophils enhance inflammatory monocyte recruitment and lung
macrophage population expansion
We next considered whether eosinophils also could contribute to host defenses against asper-
gillosis by directly or indirectly recruiting other phagocytes to the site of infection. Therefore,
we assessed the number of leukocytes (CD45+ cells) three days after infection with 5x107 A.
IL-23/IL-17-Producing Eosinophils in Aspergillosis
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fumigatus conidia in the lungs of BALB/c and ΔdblGATA-1 mice. We found that BALB/c mice
had approximately 2x106 more CD45+ cells than ΔdblGATA-1 mice (Fig 5A). This difference
could not be accounted for by the lack of eosinophils in ΔdblGATA-1 mice, as their numbers
averaged 1.7x105 ± 0.2x105 in BALB/c mice at the same 3 day time point (Fig 4B).
Fig 3. Confocal microscopy demonstrates intracellular IL-23p19 and IL-17A in eosinophils. Mice were challenged with A. fumigatus, treated with
monensin, subjected to bronchoalveolar lavage and the lavaged cells analyzed by confocal microscopy as in Methods. Eosinophils were identified by staining
for EPX (A and B) or MBP (C and D). Cells were analyzed 8 (A and C) and 54 (B and D) hours post-infection. The Merge images superimpose all 3 fluorescent
images. The Merge+DIC images are the Merge images superimposed on differential interference contrast (DIC) images. Arrows and arrowheads point to
eosinophils and conidia, respectively. Scale bars, 5 μm (A and B) and 2 μm (C and D). Photomicrographs are representative images from 3 independent
experiments.
doi:10.1371/journal.ppat.1006175.g003
IL-23/IL-17-Producing Eosinophils in Aspergillosis
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Considering that eosinophils were found to be sources of IL-23 and IL-17 in acute aspergil-
losis (Figs 1 and 2) and as these cytokines play a significant role in the recruitment of neutro-
phils [27], we evaluated the degree of lung neutrophilia one and three days post-infection in
BALB/c and ΔdblGATA-1 mice. We found no differences in neutrophil numbers between
groups (Fig 5B). However, when we assessed the number of inflammatory monocytes (Siglec-
F- CD11b+ CCR-2+) and lung macrophages (Siglec-F+ CD11c+), we found that both phagocyte
populations increased from day one to day three in BALB/c mice but not in ΔdblGATA-1
mice (Fig 5C and 5D). In fact, at three days post-infection, ΔdblGATA-1 mice had fewer
inflammatory monocytes and macrophages than BALB/c mice. These data suggest that lack of
eosinophils disrupts inflammatory monocyte recruitment, which then hampers lung macro-
phage expansion as inflammatory monocytes differentiate into macrophages and DCs at sites
of inflammation [28,29]. Nevertheless, percent killing of conidia by inflammatory monocytes
and neutrophils was not significantly different when comparing BALB/c with ΔdblGATA-1
mice (S2 Fig).
Fig 4. Eosinophils associate with and kill A. fumigatus conidia. BALB/c mice were infected with 5x107 FLARE conidia. One and three days post-
infection, lung single cell suspensions were assessed for eosinophils (Siglec-F+ CD11c-), and their capacity to associate with and kill conidia. (A)
Representative FACS plots at days 1 and 3. Representative plots from 3 experiments with 12 mice in each group. (B) Left panel. Percentage of eosinophils
among total live lung cells at day 0 (uninfected,▲), day 1 (●) and day 3 (■) post-infection. Differences were statistically not significant (ns). Right panel. Total
number of eosinophils in the lungs at day 0 (uninfected,▲), day 1 (●) and day 3 (■) post-infection. Plot from 3 separate experiments with a total of 12 mice
per group. (C) Eosinophils gated as in A were analyzed for whether they had associated with conidia and if so whether the conidia were alive (gate R1) or
dead (gate R2). Representative FACS plots at days 1 and 3 are shown. Plot representative of 3 separate experiments with 6 mice per group. (D) Left panel.
The number of eosinophils associated with conidia was calculated by multiplying the sum of the percentages in gates R1 and R2 by the total number of
eosinophils. Significant differences between days 1 and days 3 were not seen. Right panel. Conidial killing by eosinophils was assessed at days 1 and 3
using the FLARE assay. Percent conidial killing was calculated by the quotient of events in gate R2 and the sum of R1 and R2 multiplied by 100. An increase
in conidial killing was observed from day one (mean = 36.9%) to day three (mean = 68.6%) post-infection. Data were statistically analyzed using t-tests, * =
p < 0.05, ** = p < 0.01, ns = p > 0.05. Plot from three separate experiments with a total of 6 mice per group.
doi:10.1371/journal.ppat.1006175.g004
IL-23/IL-17-Producing Eosinophils in Aspergillosis
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Eosinopenia renders mice more susceptible to acute aspergillosis
Infecting BALB/c and ΔdblGATA-1 mice with 5x107 A. fumigatus conidia from the AF293
strain rendered no casualties (Fig 6A). However, after infection with the same inoculum of the
CEA10 strain, which has been shown to be a more virulent strain in mouse models of acute
aspergillosis [30,31,32,33,34], ΔdblGATA-1 mice had significantly higher mortality compared
with BALB/c mice (Fig 6B).
To examine why lack of eosinophils was associated with increased mortality, we looked at
CFUs in lungs, kidneys, liver and spleen 2d post infection. ΔdblGATA-1 mice had a modest
but statistically significant decrease in lung CFUs following challenge with both A. fumigatus
strains (Fig 6C). Extrapulmonary dissemination was observed but did not significantly differ
when comparing BALB/c and ΔdblGATA-1 mice (Fig 6C). The paradoxical decreased number
of CFUs in the lung in the ΔdblGATA-1 mice suggested that the mice could be succumbing to
a robust inflammatory response rather than uncontrolled infection. To study this further, we
looked at lung histopathology in BALB/c and ΔdblGATA-1 mice 2d following infection with
the AF293 and CEA10 strains of A. fumigatus (S3 Fig). In both groups, H&E stained sections
revealed inflammatory cells in the airways and mainly nearby airspaces. The inflammatory
Fig 5. Eosinopenic mice show decreased recruitment of inflammatory monocytes to the lungs and
reduced expansion of lung macrophages following challenge with A. fumigatus. Lung single-cell
suspensions from BALB/c (blue circle) and ΔdblGATA-1 (eosinopenic; red square) mice infected with 5x107
AF293 conidia were made one and three days post-infection and assessed for leukocyte populations. (A) Lack
of eosinophils correlates with lower levels of CD45+ cells in the lungs three days after infection with 5x107
conidia. ** = p < 0.001. (B) Neutrophil numbers in the lungs do not significantly differ comparing day 1 to day 3
post-infection. Furthermore, lack of eosinophils does not significantly affect neutrophil recruitment. p>0.05
(ns). (C,D) Inflammatory monocyte and lung macrophage numbers failed to increase in the absence of
eosinophils. ** = p < 0.01, **** = p < 0.0001 Plots are aggregates from 3 separate experiments with 6–13
mice per group.
doi:10.1371/journal.ppat.1006175.g005
IL-23/IL-17-Producing Eosinophils in Aspergillosis
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cells were predominantly composed of histiocyctes admixed with sparse lymphocytes and
neutrophils. Eosinophils were also noted in the lung sections from the BALB/c but not
ΔdblGATA-1 mice. Gomori’s methenamine silver (GMS) stained sections demonstrated
numerous conidia and hyphae in the inflamed areas of the lungs. Interestingly, the lungs from
CEA10 infected wild-type and ΔdblGATA type mice revealed relatively more hyphal growth
Fig 6. Eosinophils protect against mortality in acute infection with the CEA10 strain but not with the AF293 strain of A. fumigatus. Mortality study
of BALB/c (blue) and ΔdblGATA-1 (red) mice infected with 5x107 conidia (A) AF293 conidia and (B) CEA10 conidia. Kaplan-Meyer curves show combined
data from two (for AF293) and three (for CEA10) separate experiments, each with 5 mice per group. * = p < 0.05. (C) Organ CFU 2d post infection of BALB/
c and ΔdblGATA-1 mice with 5x107 conidia of the indicated A. fumigatus strain. Data are from 2 separate experiments, one with 3 mice per group and the
other with 2 mice per group. * = p < 0.05.
doi:10.1371/journal.ppat.1006175.g006
IL-23/IL-17-Producing Eosinophils in Aspergillosis
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compared to those infected with AF293. However, despite the great difference in fungal germi-
nation, histology at two days post-infection did not demonstrate discernable differences in the
inflammatory response when comparing the wild-type and eosinopenic mice infected by the
two A. fumigatus strains (S3 and S4 Figs).
Eosinophils co-produce IL-23p19 and IL-17AF in allergic asthma
As eosinophils are thought to drive many of the pathological findings in allergic asthma, and
as increased levels of IL-17 have recently been correlated with severity of asthma symptoms
[35], we next assessed whether eosinophils can also produce IL-23p19 and/or IL-17 in murine
models of allergic asthma. Two established models of acute allergic asthma were chosen. In the
first, mice were sensitized and challenged with A. fumigatus crude protein extracts (Af cpe)
[36]. In the second model, sensitization was achieved with OVA admixed with aluminum
hydroxide and challenge was performed with aerosolized OVA [37] (Fig 7A). In each of the
allergic asthma models, eosinophils produced both IL-23p19 and IL-17AF (Fig 7B). In Af cpe
sensitized and challenged mice, a significantly higher proportion of lung leukocytes were iden-
tified as eosinophils when compared to the OVA asthma model. Despite this difference, in
both models a similar absolute number of eosinophils were recruited to the lungs (Fig 7C).
Greater than 90% of IL-23p19+ and IL-17AF+ cells were identified as eosinophils regardless
of sensitizing allergen (Fig 8A and 8B). On average, 35.1% of lung cells produced IL-23p19 in
the A. fumigatus asthma model, compared to 22.5% in the OVA model (Fig 8A and 8C). Sensi-
tization with A. fumigatus cpe elicited also elicited a higher percentage of IL-17AF+ cells com-
pared with OVA sensitization (Fig 8B and 8D). Lung macrophages, inflammatory monocytes
and neutrophils also produced IL-17AF, although at levels below those seen in eosinophils (S5
Fig). However, among the myeloid populations studied, only eosinophils were significant pro-
ducers of IL-23p19 (S6 Fig).
Discussion
The data presented here establish a new paradigm in acute and allergic aspergillosis whereby
eosinophils act not only as effector cells but also as immunomodulatory cells driving the
IL-23/IL-17 axis and contributing to inflammatory cell recruitment. Thus, following acute
challenge with A. fumigatus conidia, eosinophils associated with and killed A. fumigatus
conidia and ΔdblGATA-1 mice deficient in eosinophils were hypersusceptible to invasive
aspergillosis. In acute and allergic models of aspergillosis, pulmonary eosinophils were found
to be prominent sources of IL-23p19 and IL-17. Finally, following acute A. fumigatus chal-
lenge, ΔdblGATA-1 mice had fewer total leukocytes, inflammatory monocytes and lung mac-
rophages compared to wild-type mice.
Although over 95% of the eosinophils were found to be positive for IL-23p19 and IL-17A
(Figs 1 and 2), only 18% and 8% of eosinophils were found to associate with conidia one and
three days post-infection, respectively (Fig 4). This disparity suggests that direct association
with A. fumigatus is not necessary for the production of IL-23p19 or IL-17A. The milieu in
which the eosinophils are stimulated appears to be important as co-incubation of bone-mar-
row derived eosinophils with A. fumigatus conidia or zymosan failed to elicit IL-23 or IL-17
production as measured by ELISA and ICS. These findings underscore the plasticity of eosino-
phils; as with other immune cells, subsets appear to exist. For example, in the small intestine,
eosinophils constitutively secrete IL-1 receptor antagonist which downregulates TH17 cells
[38] whereas in response to parasite challenge eosinophils promote TH2 immunity [39]. Future
work should focus on determining the extrinsic and intrinsic molecular pathways that stimu-
late eosinophils to produce IL-23 and IL-17.
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IL-23p19 and IL-17 production was observed in pulmonary eosinophils recruited to the
lungs not only in models of acute and allergic aspergillosis but also in a model of allergic
asthma induced by sensitization to OVA (Figs 7 and 8). As eosinophils have been reported to
express IL-23R [40], this suggests an autocrine amplification loop may be occurring whereby
eosinophils release IL-23 which directly feeds back on itself via IL-23R to enhance IL-17 pro-
duction. As a precedent, eosinophils express IL-5R and have IL-5 in their granules [40]. Other
IL-23-producing cell types, including alveolar macrophages, have been found to produce IL-
17 under defined conditions [20,41]. We postulate that eosinophils may be contributing to the
IL-23/IL-17 axis under a broad spectrum of disease states. In support of this hypothesis, three
other groups have reported evidence for eosinophil-derived IL-17 [42–43]. Using a reporter
IL-17A-EGFP mouse line, Shimura et al. demonstrated that EGFP+ eosinophils in the
Fig 7. Eosinophils co-produce IL-23p19 and IL-17AF in two different models of asthma. (A) Schematic of sensitization and challenge timeline for
asthma models. C57Bl/6 mice were sensitized with either 20 ug of OVA in alum or 200 ug of A. fumigatus crude protein extracts (Af cpe) by IP injections
twice in two week intervals. Two weeks after the second sensitization, mice were challenged with either OVA or Af cpe by aerosol exposure on days 28, 29,
and 30 after the first sensitization. Two days after the last challenge, mice were treated with 500 ug of monensin by IP injection. Six hours after the
monensin treatment, ICS was performed in lung single cell suspensions. (B) Lung cells in the eosinophil (Siglec-F+ CD11c-) gate were examined for
production of IL-23p19 and IL-17AF. Histograms show the shift in signal intensity for each cytokine compared to FMO controls. (C) Percent and number of
eosinophils in the lungs of Af cpe and OVA sensitized mice. Although eosinophils made up a significantly higher proportion of lung leukocytes in mice
sensitized and challenged with Af cpe compared to the OVA group, the number of eosinophils did not differ statistically between the two groups (n = 5). ** =
p < 0.01; ns = p > 0.05.
doi:10.1371/journal.ppat.1006175.g007
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peritoneum 6 hours following an IP LPS injection [43]. In humans, Molet et al. demonstrated
IL-17 gene and protein expression in eosinophils obtained from the sputum, bronchoalveolar
lavage fluid and blood of asthmatic subjects [42]. Lastly, Kobayashi et al. detected IL-17 in the
supernatants of human eosinophils stimulated with monosodium urate crystals [44].
IL-23 is a key cytokine promoting and maintaining IL-17-producing cells, particularly
TH17 cells [11,45]. Remarkably, whereas dendritic cells and macrophages are thought to be the
primary sources of IL-23 in tissue [45,46]; in our aspergillosis models we found eosinophils
were the major cell type in the lungs producing IL-23. Thus, in the acute aspergillosis model
Fig 8. Eosinophils are a significant source of local IL-23 and IL-17AF in asthma. C57Bl/6 mice were sensitized and
challenged with Af cpe or OVA as in Fig 7A. Lung cells from monensin-treated mice were then analyzed by ICS. (A and B) IL-
23p19+ cells (A) and IL-17AF+ cells were analyzed for expression of Siglec-F and CD11c. Boxes denote the eosinophil
(Siglec-F+ CD11c-) gate. The numbers under the box are mean ± SD (n = 5 mice per group). The vast majority of cells that
stained positive for IL-23p19 and IL-17AF were in the eosinophil gate. (C,D) Percent of live lung cells that stained for IL-
23p19 (C) and IL-17AF (D) after Af cpe and OVA sensitizations. Sensitization with Af cpe induced higher levels of IL-23p19+
and IL-17AF+ cells than OVA sensitization. * = p < 0.05.
doi:10.1371/journal.ppat.1006175.g008
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and both allergic models, the cells that stained the brightest for IL-23p19 were nearly all eosin-
ophils. Their identity as eosinophils was confirmed by sorting and by the loss of this popula-
tion in the ΔdblGATA-1 mice. Significantly, following challenge with A. fumigatus conidia,
levels of the functional IL-23 heterodimer were dramatically reduced in the BALF of mice that
lacked eosinophils compared to wild-type controls. Two IL-23p19 antagonists, tildrakizumab
and guselkumab, are undergoing clinical trials for the treatment of autoimmune and allergic
disease [46]. For the subset of these diseases in which eosinophilia is seen, our data suggest that
targeting eosinophils could have therapeutic efficacy while avoiding potential toxicities such as
impaired host defenses to infections that could occur following global inhibition of the IL-23/
IL-17 axis [46].
In mouse models of asthma, the absence of eosinophils correlates with decreased airway
hyperresponsiveness (AHR) and decreased mucus production [47]; these findings are also
found in mice lacking IL-17 signaling [48,49]. Another example of functional overlap is the
finding that IL-17 signaling and eosinophil co-culture with epithelial cells have each been
shown to up-regulate Mucin 5AC, a mucin protein produced by bronchial airway goblet cells
[48,50,51]. The convergence between IL-17 and eosinophils found in our models of allergic
asthma point to a novel mechanism by which eosinophils contribute to the pathogenesis of
asthma in a manner that is independent of TH2-driven inflammation. If this phenomenon
holds up in humans, as is supported by the data of Molet et al. [42], it could be of use to better
stratifying asthma type, as heterogeneity in this disease has prevented the success of some tar-
geted asthma therapies [48,52].
Clinically, asthma features episodic shortness of breath accompanied by wheezing due to
AHR. However, it has been increasingly recognized that a heterogeneous group of immuno-
logical processes drives these hallmark symptoms [48,53]. Individualizing therapy based on
the immunological drivers has the potential to improve therapeutic outcome, which is relevant
considering many patients fail to respond to standard treatment [53,54]. Stratification based
on the predominant cellular infiltrate found in induced sputum has delineated four distinct
types of asthma: eosinophilic, neutrophilic, mixed granulocytic and paucigranulocytic [55]. It
will be interesting to assess the presence of IL-23+ IL-17+ eosinophils in each of these types, as
even in neutrophilic and paucigranulocytic asthma a small number of eosinophils is present
[55].
While eosinophils act as drivers of inflammation and tissue remodeling in asthma [39,52,
56], they play a protective role in models of acute pulmonary aspergillosis. Eosinopenic mice
challenged with a relatively virulent strain of A. fumigatus had increased mortality compared
to wild-type mice (Fig 6) despite similar CFUs and no striking differences in lung pathology
(Figs 6, S3 and S4). In contrast, Lilly et al. found Aspergillus-infected mice lacking eosinophils
had higher fungal burdens, as measured by A. fumigatus 18S rRNA and fungal germination
[10].
How eosinophils protect hosts still needs to be more fully defined and may be multifacto-
rial. Eosinophils directly kill A. fumigatus in vivo (Fig 4) and by contact-dependent mecha-
nisms in vitro [10]. Moreover, lysates containing eosinophil granule proteins inhibit fungal
germination [10]. However, we also found eosinophils act indirectly by promoting the recruit-
ment of inflammatory monocytes and macrophages to the lungs after infection (Fig 5). Alveo-
lar macrophages and inflammatory monocytes kill A. fumigatus conidia [29,57]. In addition,
mice depleted of inflammatory monocytes are vulnerable to A. fumigatus infection [29]. In-
terestingly, ΔdblGATA-1 mice did not have a defect in neutrophil recruitment to the lung fol-
lowing A. fumigatus challenge (Fig 5 and [10]). Moreover, in a neutropenia mouse model of
aspergillosis that features repeated aspiration of conidia from an unusual strain of A. fumigatus
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containing high cell wall chitin, decreases in fungal burden and mortality were observed in
ΔdblGATA-1 mice [9].
In the context of the damage-response framework of microbial pathogenesis [58], we posit
that eosinophils and eosinophilic production of IL-23 and IL-17 are beneficial in invasive
aspergillosis but detrimental in allergic disease. Future studies will test this hypothesis and
examine the spectrum of diseases under which eosinophils produce IL-23 and IL-17. These
data could help inform clinical studies using monoclonal antibodies and other immunomodu-
lators that target eosinophils and the IL-23/IL-17 axis.
Materials and Methods
Mice
Six- to eight-week old C57Bl/6, BALB/c, ΔdblGATA-1 mice in the BALB/c background, and
IL-17AGFP/GFP mice in the C57Bl/6 background were obtained from Jackson Laboratories and
bred in pathogen-free conditions at the University of Massachusetts Medical School (UMMS).
Ethics statement
The mouse studies were performed in accordance with protocol #1802–15 approved by the
UMMS Institutional Animal Care and Use Committee. In addition, all mouse studies were
carried out in accordance with the recommendations in the Guide for the Care and Use of
Laboratory Animals of the National Institutes of Health.
Aspergillus fumigatus culture and murine acute pulmonary aspergillosis
model
A. fumigatus from the AF293 strain was obtained from the Fungal Genetics Stock Center
(Manhattan, KS). AF293 was grown from frozen stocks on Sabouraud-dextrose agar (Remel)
slants [59,60]. The CEA10 strain was a generous gift from Robert Cramer (Geisel School of
Medicine, Hanover, NH) and grown as described [61]. Conidia were harvested by vortexing
slants with PBS containing 0.01% Tween-20 (Thermo-Fisher) and filtering the suspension
twice through a 30 μm nylon mesh folded over a conical tube. Suspensions were then washed
three times with 0.01% Tween-PBS, and re-suspended in the same solution at a concentration
of 6.67x108 conidia/mL. Mice were infected via the oro-tracheal (OT) route with 75 μL of
conidial suspension, so that each mouse received 5x107 conidia. OT infection was facilitated
by anesthetizing mice with isoflurane (Piramal Healthcare). Organ CFUs were enumerated as
in our previous studies [62,63] except the resected organs were homogenized and diluted in
PBS containing 0.01% Tween-20. The lower limit of detection was 10 CFU/organ.
Generation of bone marrow-derived eosinophils (BM-Eos)
Bone marrow cells were isolated from murine femurs and differentiated as described previ-
ously [64]. Briefly, BM cells were subjected to a gradient with Histopaque 1083 (Sigma). Inter-
phase cells were washed twice to remove any leftover Histopaque and cultured in Isocove’s
modified Dulbecco’s medium (IMDM; Life Technologies) supplemented with 10% FBS (Tis-
sue Culture Biologicals), 100 U/mL penicillin and 100 U/mL streptomycin, 1X Glutamax (Life
Technologies) and 2 μL of β-mercaptoethanol (Life Technologies). The first four days of cul-
ture, cells were stimulated with 100 ng/mL of murine stem cell factor (mSCF) (PeproTech)
and 100 ng/mL of murine FMS-like tyrosine kinase 3 ligand (mFLT3L) (PeproTech). The fol-
lowing ten days, cells were stimulated with 10 ng/mL IL-5 (R&D). Cells were fed every other
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day. Differentiation was confirmed by flow cytometry with rat mAb against murine Siglec-
F-BV421 (BD Biosciences).
BM-Eos stimulation
BM-Eos were stimulated with live or heat-killed A. fumigatus AF293 conidia, zymosan (10–
100 μg/mL; Sigma), lipopolysaccharide (LPS, 100 ng/mL; Sigma) and several cytokines at dif-
ferent concentrations and combinations for lengths of time ranging from two hours to two
days. Cytokines used to stimulate BM-Eos included IL-5 (10 ng/mL), IL-1β (1–10 ng/mL;
R&D), GM-CSF (10 ng/mL; PeproTech), IL-23 (10 ng/mL; eBiosciences), IL-17E (0.1–10 ng/
mL; R&D), IL-17AA (0.1–10 ng/mL; R&D), PGE2 (10
−5–10−3 M; Cayman Chemicals), trans-
forming growth factor-β (TGF-β) (1–10 ng/mL; eBiosciences), and IL-6 (10–100 ng/mL;
eBiosciences). When co-incubated with live A. fumigatus conidia, cultures were supplemented
with 0.5 μg/mL of voriconazole (Sigma) to prevent fungal overgrowth. Following stimulation,
supernatants were collected for ELISA. In some experiments, cells were co-incubated with
1 μM monensin in the last 5 hours of stimulation, and intracellular cytokine staining was per-
formed as described below.
Fluorescent Aspergillus Reporter (FLARE) conidia
FLARE conidia were created as described [26,65]. Briefly, 5x108 dsRed conidia (AF293) per
mL were incubated with 0.5 mg/mL 6-((6-((Biotinoyl)Amino)Hexanoyl)amino)Hexanoic
Acid, Sulfosuccinimidyl Ester, Sodium Salt (Biotin-XX, SSE) (ThermoFisher) in 50 mM car-
bonate buffer (Sigma), pH 8.3 at 4˚C for 2 h in a tube rotator. Excess Biotin-XX, SSE was
washed off with 0.1 M Tris-HCl pH 8.0 (Sigma); then conidia were incubated with 0.02 mg/
mL streptavidin conjugated to Alexa Fluor 633 (Life Technologies) away from light at room
temperature for 30 minutes. Labeling was confirmed by flow cytometry prior to infecting
animals.
Murine acute allergic asthma model
C57Bl/6 mice were sensitized two times by IP injection of 20 μg of OVA (Sigma-Aldrich) in
100 μL of Imject Alum (Thermo Scientific) or 200 μg of A. fumigatus crude protein extracts
(Af cpe) (Greer Laboratories). Sensitization occurred two weeks apart. On days 28, 29 and 30
mice were challenged with aerosolized 1% OVA or 0.25% Af cpe in saline respectively for 20
minutes as described [36].
Intracellular cytokine staining, sorting and flow cytometry
ICS was performed as previously described [66]. Briefly, mice were treated with 500 μg of
monensin (Sigma-Aldrich) by IP injection, 2 or 48 h after infection with 5x107 conidia, or 48 h
after the last challenge in the allergic asthma models. Six hours after monensin treatment, lung
single-cell suspensions were prepared using MACS lung dissociation kit as described by the
manufacturer (Miltenyl Biotec). Single-cell suspensions were enriched for leukocytes using a
Percoll (GE Healthcare) gradient [67]. Interphase cells were collected, counted with the aid of a
hemocytometer, and then co-incubated with rat anti-mouse CD16/CD32 monoclonal antibody
(mAb) 2.4G2 (BD Pharmingen) to block Fc receptors in accordance with manufacturer’s direc-
tions. Surface antigens were then stained with antibodies listed in Table 1 and with Fixable Via-
bility Dye eFluor 780 (eBioscience) or Live/Dead Blue (Life Technologies) for 30 minutes at 4 C.
After two successive wash steps, lung leukocytes were fixed in 2% paraformaldehyde (Electron
Microscopy Sciences) PBS solution for at least 15 minutes at 4 C. Fixed cells were permeabilized
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using Perm/Wash Buffer (BD Pharmingen) according to manufacturer instructions and then
stained with antibodies listed in Table 1.
For sorting IL-23p19+ IL-17A+ cells, fixed lung leukocytes were only stained for intracellu-
lar cytokines, and then sorted with BD FACSVantage DV-1 Cell Sorter (UMass Medical
School Flow Cytometry Core). FC data were acquired with a BD LSR II cytometer and ana-
lyzed using FlowJo X software (Tree Star Inc.). Gating was established using FMO controls
containing isotype control mAb conjugated with the fluorophore corresponding to the missing
antibody as described [68].
Confocal microscopy
Mice were infected with 5 x 107 A. fumigatus strain 293 conidia via oral-tracheal route. After
two or 48 h, mice received 500 μg of IP monensin, and 6 h later the mice were euthanized and
bronchoalveolar lavage fluid was collected. Cells were washed with PBS, counted, fixed with
2% paraformaldehyde buffered in PBS and washed an additional 3 times. The lavage cells were
then cytospun onto slides (Shandon Cytoslide), permeabilized for 10 minutes in 0.1% Triton-
X 100 in PBS, washed three times with PBS and blocked with 10% donkey serum in PBS for 1
h at room temperature. Cells were sequentially immunostained in 5% donkey serum with goat
polyclonal antibody (4˚C, 3 hours), Alexa fluor 594-labeled donkey anti-goat fab2 (room
Table 1. Antibodies used in flow cytometry.
Surface Markers
mAb Clone Manufacturer Isotype
Ly6G-PE-CF594 1A8 BD Biosciences Rat IgG2a
CCR-2-FITC 475301 R&D Systems Rat IgG2b
CD11c-BV 570 N418 BioLegend Armenian Hamster IgG
Siglec-F-BV 421 E50-2440 BD Biosciences Rat IgG2a
CD11b-BUV 395 M1/70 BD Biosciences Rat IgG2b
CD45-PerCP-Cy5.5 30-F11 BD Biosciences Rat IgG2b
Intracellular Markers
mAb Clone Manufacturer Isotype
IL-23p19-eFluor 660 Fc23cpg eBiosciences Rat IgG1
IL-17A-PE-Cy7 TC11-18H10.1 BioLegend Rat IgG1
IL-17AF-eFluor 660 B8KN8R eBiosciences Rat IgG2a
doi:10.1371/journal.ppat.1006175.t001
Table 2. Antibodies used in confocal microscopy.
Antibody Label Manufacturer/Catalog #
goat polyclonal anti-MBP None Santa Cruz/109316
goat polyclonal anti-EPX None Santa Cruz/19148
goat polyclonal IgG* None Santa Cruz/3887
donkey anti-goat fab2 Alexa fluor 594 Abcam/150140
rabbit polyclonal anti-IL-23p19 None Abcam/45420
rabbit polyclonal anti-IL-17A None Abcam/79065
rabbit polyclonal IgG** None Abcam/27478
donkey anti-rabbit fab2 Alexa fluor 647 Abcam/181347
* control for anti-MBP and anti-EPX.
** control for anti-IL-23p19 and anti-IL-17A.
doi:10.1371/journal.ppat.1006175.t002
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temperature, 1 hour), rabbit polyclonal antibody (4 hours, 4˚C), and Alexa fluor 647-labeled
donkey anti-rabbit fab2 fragment (45 minutes, room temperature). The specific antibodies
used, including the control antibodies, are listed in Table 2. Cell nuclei were stained with
4’6-diamino-2-phenylindole (DAPI, 1ug/ml; Sigma) and the slides were mounted with Pro-
Long Gold Antifade Mountant (Life Technologies). Images were acquired with a 63x oil
immersion objective at maximum intensity projections in sequential scan mode with a laser
confocal microscope (Leica SP8).
Cytological staining
After sorting, cells were adhered to poly-L-lysine-coated slides (Sigma-Aldrich) by cytospin-
ning 250 μL of cell suspension at 800 rpm for three minutes (Shandon Cytospin 2). Cells were
dried on the slide, and then dipped in hematoxylin solution (Thermo-Fisher) for 30 seconds.
Slides were washed in water then dipped in eosin (Thermo-Fisher) for one minute. Increasing
concentrations of ethanol (95%-100%) were used to dehydrate slides for a total of two minutes.
Finally, slides were dipped three times in Clear-Rite (Thermo Scientific) for one minute each
time. Slides were mounted using Permount (Fisher Scientific).
Cytokine quantification in bronchoalveolar lavage fluid (BALF) after
infection
BALF from BALB/c and ΔdblGATA-1 mice infected as described above was collected after
euthanasia at 60 h post-infection. Briefly, an 18 or 20 gauge plastic catheter (Temuro) was
inserted into the trachea and lungs were flushed three times with 1 mL of PBS supplemented
with cOmplete protease inhibitor cocktail (Sigma-Aldrich). BALF samples were flash frozen in
dry ice and subsequently stored in -80˚C. IL-23 heterodimer (IL-23p19/IL-12p40) was mea-
sured using R&D Quantikine ELISA kit.
Statistical analysis
Statistical tests were performed using GraphPad Prism 6. The Student’s t-test was used to com-
pare the means of two groups with the Bonferroni correction applied for multiple compari-
sons. For data sets where the mean of more than two groups was compared, 2-way ANOVA
was performed using Tukey’s multiple comparison correction. In comparing Kaplan-Meyer
survival curves, the Mantel-Cox test was used.
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